Literature DB >> 24375535

Dysfunctions of decision-making and cognitive control as transdiagnostic mechanisms of mental disorders: advances, gaps, and needs in current research.

Thomas Goschke1.   

Abstract

Disadvantageous decision-making and impaired volitional control over actions, thoughts, and emotions are characteristics of a wide range of mental disorders such as addiction, eating disorders, depression, and anxiety disorders and may reflect transdiagnostic core mechanisms and possibly vulnerability factors. Elucidating the underlying neurocognitive mechanisms is a precondition for moving from symptom-based to mechanism-based disorder classifications and ultimately mechanism-targeted interventions. However, despite substantial advances in basic research on decision-making and cognitive control, there are still profound gaps in our current understanding of dysfunctions of these processes in mental disorders. Central unresolved questions are: (i) to which degree such dysfunctions reflect transdiagnostic mechanisms or disorder-specific patterns of impairment; (ii) how phenotypical features of mental disorders relate to dysfunctional control parameter settings and aberrant interactions between large-scale brain systems involved in habit and reward-based learning, performance monitoring, emotion regulation, and cognitive control; (iii) whether cognitive control impairments are consequences or antecedent vulnerability factors of mental disorders; (iv) whether they reflect generalized competence impairments or context-specific performance failures; (v) whether not only impaired but also chronic over-control contributes to mental disorders. In the light of these gaps, needs for future research are: (i) an increased focus on basic cognitive-affective mechanisms underlying decision and control dysfunctions across disorders; (ii) longitudinal-prospective studies systematically incorporating theory-driven behavioural tasks and neuroimaging protocols to assess decision-making and control dysfunctions and aberrant interactions between underlying large-scale brain systems; (iii) use of latent-variable models of cognitive control rather than single tasks; (iv) increased focus on the interplay of implicit and explicit cognitive-affective processes; (v) stronger focus on computational models specifying neurocognitive mechanisms underlying phenotypical expressions of mental disorders.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cognitive control; decision-making; large-scale brain systems; transdiagnostic mechanisms; volition

Mesh:

Year:  2014        PMID: 24375535      PMCID: PMC6878557          DOI: 10.1002/mpr.1410

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  133 in total

Review 1.  From reinforcement learning models to psychiatric and neurological disorders.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Nat Neurosci       Date:  2011-02       Impact factor: 24.884

Review 2.  Addiction.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Annu Rev Psychol       Date:  2002-06-10       Impact factor: 24.137

Review 3.  Executive functions and self-regulation.

Authors:  Wilhelm Hofmann; Brandon J Schmeichel; Alan D Baddeley
Journal:  Trends Cogn Sci       Date:  2012-02-13       Impact factor: 20.229

4.  Separate neural systems value immediate and delayed monetary rewards.

Authors:  Samuel M McClure; David I Laibson; George Loewenstein; Jonathan D Cohen
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

Review 5.  The role of the inferior frontal junction area in cognitive control.

Authors:  Marcel Brass; Jan Derrfuss; Birte Forstmann; D Yves von Cramon
Journal:  Trends Cogn Sci       Date:  2005-07       Impact factor: 20.229

6.  Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala.

Authors:  Amit Etkin; Tobias Egner; Daniel M Peraza; Eric R Kandel; Joy Hirsch
Journal:  Neuron       Date:  2006-09-21       Impact factor: 17.173

Review 7.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex.

Authors:  Brian P Ramos; Amy F T Arnsten
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

Review 8.  Model-based fMRI and its application to reward learning and decision making.

Authors:  John P O'Doherty; Alan Hampton; Hackjin Kim
Journal:  Ann N Y Acad Sci       Date:  2007-04-07       Impact factor: 5.691

Review 9.  Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance.

Authors:  Luiz Pessoa; Ralph Adolphs
Journal:  Nat Rev Neurosci       Date:  2010-11       Impact factor: 34.870

10.  Why people change? The role of cognitive-control processes in the onset and cessation of substance abuse disorders.

Authors:  Gerhard Bühringer; Hans-Ulrich Wittchen; Katrin Gottlebe; Claudia Kufeld; Thomas Goschke
Journal:  Int J Methods Psychiatr Res       Date:  2008-06       Impact factor: 4.035

View more
  57 in total

1.  Trait self-control is predicted by how reward associations modulate Stroop interference.

Authors:  Max Wolff; Klaus-Martin Krönke; Thomas Goschke
Journal:  Psychol Res       Date:  2015-09-24

Review 2.  The need for a behavioural science focus in research on mental health and mental disorders.

Authors:  Hans-Ulrich Wittchen; Susanne Knappe; Gerhard Andersson; Ricardo Araya; Rosa M Banos Rivera; Michael Barkham; Per Bech; Tom Beckers; Thomas Berger; Matthias Berking; Carmen Berrocal; Christina Botella; Per Carlbring; Guy Chouinard; Francesc Colom; Claudio Csillag; Pim Cujipers; Daniel David; Paul M G Emmelkamp; Cecilia A Essau; Giovanni A Fava; Thomas Goschke; Dirk Hermans; Stefan G Hofmann; Wolfgang Lutz; Peter Muris; Thomas H Ollendick; Filip Raes; Winfried Rief; Heleen Riper; Eliana Tossani; Saskia van der Oord; Bram Vervliet; Josep M Haro; Gunter Schumann
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

Review 3.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

4.  Prefrontal Cortical Inactivations Decrease Willingness to Expend Cognitive Effort on a Rodent Cost/Benefit Decision-Making Task.

Authors:  Jay G Hosking; Paul J Cocker; Catharine A Winstanley
Journal:  Cereb Cortex       Date:  2015-01-16       Impact factor: 5.357

5.  The unity and diversity of executive functions: A systematic review and re-analysis of latent variable studies.

Authors:  Justin E Karr; Corson N Areshenkoff; Philippe Rast; Scott M Hofer; Grant L Iverson; Mauricio A Garcia-Barrera
Journal:  Psychol Bull       Date:  2018-08-06       Impact factor: 17.737

6.  Recent Advances in Laboratory Assessment of Emotion Regulation.

Authors:  Saren H Seeley; Emmanuel Garcia; Douglas S Mennin
Journal:  Curr Opin Psychol       Date:  2015-02-17

Review 7.  Chronic pain and mental health: integrated solutions for global problems.

Authors:  Brandon A Kohrt; James L Griffith; Vikram Patel
Journal:  Pain       Date:  2018-09       Impact factor: 6.961

Review 8.  Understanding comorbidity among internalizing problems: Integrating latent structural models of psychopathology and risk mechanisms.

Authors:  Benjamin L Hankin; Hannah R Snyder; Lauren D Gulley; Tina H Schweizer; Patricia Bijttebier; Sabine Nelis; Gim Toh; Michael W Vasey
Journal:  Dev Psychopathol       Date:  2016-11

9.  Do executive functions explain the covariance between internalizing and externalizing behaviors?

Authors:  Alexander S Hatoum; Soo Hyun Rhee; Robin P Corley; John K Hewitt; Naomi P Friedman
Journal:  Dev Psychopathol       Date:  2017-11-16

Review 10.  Transdiagnostic impairment of cognitive control in mental illness.

Authors:  Lisa M McTeague; Madeleine S Goodkind; Amit Etkin
Journal:  J Psychiatr Res       Date:  2016-08-05       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.